HAMP and hemochromatosis type 1: Indeed, multiple hepcidin mimetics have been shown to prevent iron overload in mouse models of hemochromatosis, improve anemia in a mouse model of thalassemia intermedia, and control polycythemia in a mouse model of polycythemia vera (72–74).